aluates Reports

$ 0.0

Automative

Global Drugs Based on TGF-β1 Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-4F10281

Global Drugs Based on TGF β1 Market Insights Forecast to 2028

BUY CHAPTERS

Global Drugs Based on TGF-β1 Market Research Report 2025

Code: QYRE-Auto-4F10281

Report

July 2025

Pages:63

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Shionogi

Drugs Based on TGF-β1 Market Size

The global market for Drugs Based on TGF-β1 was valued at US$ 1490 million in the year 2024 and is projected to reach a revised size of US$ 2362 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Drugs Based on TGF-β1 Market

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drugs Based on TGF-β1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs Based on TGF-β1.

The Drugs Based on TGF-β1 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs Based on TGF-β1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs Based on TGF-β1 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drugs Based on TGF-β1 Market Report

Report Metric	Details
Report Name	Drugs Based on TGF-β1 Market
Accounted market size in year	US$ 1490 million
Forecasted market size in 2031	US$ 2362 million
CAGR	6.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Pirfenidone Galunisertib Others
Segment by Application	IPF Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Shionogi Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs Based on TGF-β1 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drugs Based on TGF-β1 Market growing?

Ans: The Drugs Based on TGF-β1 Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Drugs Based on TGF-β1 Market size in 2031?

Ans: The Drugs Based on TGF-β1 Market size in 2031 will be US$ 2362 million.

Who are the main players in the Drugs Based on TGF-β1 Market report?

Ans: The main players in the Drugs Based on TGF-β1 Market are Roche, Shionogi Ltd

What are the Application segmentation covered in the Drugs Based on TGF-β1 Market report?

Ans: The Applications covered in the Drugs Based on TGF-β1 Market report are IPF, Cancer, Others

What are the Type segmentation covered in the Drugs Based on TGF-β1 Market report?

Ans: The Types covered in the Drugs Based on TGF-β1 Market report are Pirfenidone, Galunisertib, Others

Recommended Reports

Related Drug Markets

Biologics & Cell Therapy

Oncology & Specialty Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs Based on TGF-β1 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Pirfenidone

1.2.3 Galunisertib

1.2.4 Others

1.3 Market by Application

1.3.1 Global Drugs Based on TGF-β1 Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 IPF

1.3.3 Cancer

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs Based on TGF-β1 Market Perspective (2020-2031)

2.2 Global Drugs Based on TGF-β1 Growth Trends by Region

2.2.1 Global Drugs Based on TGF-β1 Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drugs Based on TGF-β1 Historic Market Size by Region (2020-2025)

2.2.3 Drugs Based on TGF-β1 Forecasted Market Size by Region (2026-2031)

2.3 Drugs Based on TGF-β1 Market Dynamics

2.3.1 Drugs Based on TGF-β1 Industry Trends

2.3.2 Drugs Based on TGF-β1 Market Drivers

2.3.3 Drugs Based on TGF-β1 Market Challenges

2.3.4 Drugs Based on TGF-β1 Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs Based on TGF-β1 Players by Revenue

3.1.1 Global Top Drugs Based on TGF-β1 Players by Revenue (2020-2025)

3.1.2 Global Drugs Based on TGF-β1 Revenue Market Share by Players (2020-2025)

3.2 Global Drugs Based on TGF-β1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drugs Based on TGF-β1 Revenue

3.4 Global Drugs Based on TGF-β1 Market Concentration Ratio

3.4.1 Global Drugs Based on TGF-β1 Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs Based on TGF-β1 Revenue in 2024

3.5 Global Key Players of Drugs Based on TGF-β1 Head office and Area Served

3.6 Global Key Players of Drugs Based on TGF-β1, Product and Application

3.7 Global Key Players of Drugs Based on TGF-β1, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs Based on TGF-β1 Breakdown Data by Type

4.1 Global Drugs Based on TGF-β1 Historic Market Size by Type (2020-2025)

4.2 Global Drugs Based on TGF-β1 Forecasted Market Size by Type (2026-2031)

5 Drugs Based on TGF-β1 Breakdown Data by Application

5.1 Global Drugs Based on TGF-β1 Historic Market Size by Application (2020-2025)

5.2 Global Drugs Based on TGF-β1 Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drugs Based on TGF-β1 Market Size (2020-2031)

6.2 North America Drugs Based on TGF-β1 Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drugs Based on TGF-β1 Market Size by Country (2020-2025)

6.4 North America Drugs Based on TGF-β1 Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs Based on TGF-β1 Market Size (2020-2031)

7.2 Europe Drugs Based on TGF-β1 Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drugs Based on TGF-β1 Market Size by Country (2020-2025)

7.4 Europe Drugs Based on TGF-β1 Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drugs Based on TGF-β1 Market Size (2020-2031)

8.2 Asia-Pacific Drugs Based on TGF-β1 Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drugs Based on TGF-β1 Market Size by Region (2020-2025)

8.4 Asia-Pacific Drugs Based on TGF-β1 Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drugs Based on TGF-β1 Market Size (2020-2031)

9.2 Latin America Drugs Based on TGF-β1 Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drugs Based on TGF-β1 Market Size by Country (2020-2025)

9.4 Latin America Drugs Based on TGF-β1 Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs Based on TGF-β1 Market Size (2020-2031)

10.2 Middle East & Africa Drugs Based on TGF-β1 Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2020-2025)

10.4 Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Drugs Based on TGF-β1 Introduction

11.1.4 Roche Revenue in Drugs Based on TGF-β1 Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Shionogi Ltd

11.2.1 Shionogi Ltd Company Details

11.2.2 Shionogi Ltd Business Overview

11.2.3 Shionogi Ltd Drugs Based on TGF-β1 Introduction

11.2.4 Shionogi Ltd Revenue in Drugs Based on TGF-β1 Business (2020-2025)

11.2.5 Shionogi Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Shionogi

List of Tables

Table 1. Global Drugs Based on TGF-β1 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Pirfenidone

Table 3. Key Players of Galunisertib

Table 4. Key Players of Others

Table 5. Global Drugs Based on TGF-β1 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Drugs Based on TGF-β1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Drugs Based on TGF-β1 Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Drugs Based on TGF-β1 Market Share by Region (2020-2025)

Table 9. Global Drugs Based on TGF-β1 Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Drugs Based on TGF-β1 Market Share by Region (2026-2031)

Table 11. Drugs Based on TGF-β1 Market Trends

Table 12. Drugs Based on TGF-β1 Market Drivers

Table 13. Drugs Based on TGF-β1 Market Challenges

Table 14. Drugs Based on TGF-β1 Market Restraints

Table 15. Global Drugs Based on TGF-β1 Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Drugs Based on TGF-β1 Market Share by Players (2020-2025)

Table 17. Global Top Drugs Based on TGF-β1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on TGF-β1 as of 2024)

Table 18. Ranking of Global Top Drugs Based on TGF-β1 Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Drugs Based on TGF-β1 Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Drugs Based on TGF-β1, Headquarters and Area Served

Table 21. Global Key Players of Drugs Based on TGF-β1, Product and Application

Table 22. Global Key Players of Drugs Based on TGF-β1, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Drugs Based on TGF-β1 Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Drugs Based on TGF-β1 Revenue Market Share by Type (2020-2025)

Table 26. Global Drugs Based on TGF-β1 Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Drugs Based on TGF-β1 Revenue Market Share by Type (2026-2031)

Table 28. Global Drugs Based on TGF-β1 Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Drugs Based on TGF-β1 Revenue Market Share by Application (2020-2025)

Table 30. Global Drugs Based on TGF-β1 Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Drugs Based on TGF-β1 Revenue Market Share by Application (2026-2031)

Table 32. North America Drugs Based on TGF-β1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Drugs Based on TGF-β1 Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Drugs Based on TGF-β1 Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Drugs Based on TGF-β1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Drugs Based on TGF-β1 Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Drugs Based on TGF-β1 Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Drugs Based on TGF-β1 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Drugs Based on TGF-β1 Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Drugs Based on TGF-β1 Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Drugs Based on TGF-β1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Drugs Based on TGF-β1 Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Drugs Based on TGF-β1 Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Drugs Based on TGF-β1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2026-2031) & (US$ Million)

Table 47. Roche Company Details

Table 48. Roche Business Overview

Table 49. Roche Drugs Based on TGF-β1 Product

Table 50. Roche Revenue in Drugs Based on TGF-β1 Business (2020-2025) & (US$ Million)

Table 51. Roche Recent Development

Table 52. Shionogi Ltd Company Details

Table 53. Shionogi Ltd Business Overview

Table 54. Shionogi Ltd Drugs Based on TGF-β1 Product

Table 55. Shionogi Ltd Revenue in Drugs Based on TGF-β1 Business (2020-2025) & (US$ Million)

Table 56. Shionogi Ltd Recent Development

Table 57. Research Programs/Design for This Report

Table 58. Key Data Information from Secondary Sources

Table 59. Key Data Information from Primary Sources

Table 60. Authors List of This Report

List of Figures

Figure 1. Drugs Based on TGF-β1 Picture

Figure 2. Global Drugs Based on TGF-β1 Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drugs Based on TGF-β1 Market Share by Type: 2024 VS 2031

Figure 4. Pirfenidone Features

Figure 5. Galunisertib Features

Figure 6. Others Features

Figure 7. Global Drugs Based on TGF-β1 Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Drugs Based on TGF-β1 Market Share by Application: 2024 VS 2031

Figure 9. IPF Case Studies

Figure 10. Cancer Case Studies

Figure 11. Others Case Studies

Figure 12. Drugs Based on TGF-β1 Report Years Considered

Figure 13. Global Drugs Based on TGF-β1 Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Drugs Based on TGF-β1 Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Drugs Based on TGF-β1 Market Share by Region: 2024 VS 2031

Figure 16. Global Drugs Based on TGF-β1 Market Share by Players in 2024

Figure 17. Global Top Drugs Based on TGF-β1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on TGF-β1 as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Drugs Based on TGF-β1 Revenue in 2024

Figure 19. North America Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Drugs Based on TGF-β1 Market Share by Country (2020-2031)

Figure 21. United States Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Drugs Based on TGF-β1 Market Share by Country (2020-2031)

Figure 25. Germany Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Drugs Based on TGF-β1 Market Share by Region (2020-2031)

Figure 33. China Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Drugs Based on TGF-β1 Market Share by Country (2020-2031)

Figure 41. Mexico Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Drugs Based on TGF-β1 Market Share by Country (2020-2031)

Figure 45. Turkey Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Drugs Based on TGF-β1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Roche Revenue Growth Rate in Drugs Based on TGF-β1 Business (2020-2025)

Figure 49. Shionogi Ltd Revenue Growth Rate in Drugs Based on TGF-β1 Business (2020-2025)

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Recombinant Human Transforming Growth Factor β Market Research Report 2024

Global Activin A Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Activin A Human Market Research Report 2024

Global Human Activin A Market Insights Forecast to 2030

Global Noggin Protein Market Research Report 2024

Global TGFB3 ELISA Kits Market Research Report 2024

Global Recombinant Mouse EGF Protein Market Research Report 2025

Global Mouse EGF Protein Market Research Report 2025

Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antifibrotic Drugs Market Insights Forecast to 2030

Global Cutaneous Fibrosis Drugs Market Insights Forecast to 2030

Global Myostatin Market Research Report 2024

Global Cell Therapy Growth Factors Market Research Report 2024

Global Fibroblast Growth Factor 2 FGF 2 Market Research Report 2025

Innovative Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Innovative Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

FGF 2 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

VEGF Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Interferon Beta 1b Drugs Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions